“Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A Single Center Study”. The Planet, vol. 7, no. 01, Feb. 2024, pp. 255-66, https://bdjournals.org/index.php/planet/article/view/427.